This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
In the article "The Efficacy of Apraclonidine as an Adjunct to Timolol Therapy" published in the March issue of the Archives (1995;113:287-292), an incorrect group of participants was erroneously included in the box on page 291. The correct list of participants of the Apraclonidine Adjunctive Therapy Study Group is printed below. We apologize for the error.
Participating Principal Investigators and Affiliations
Phil Aitken, MD, University of Vermont Medical School, Burlington; Randy Craven, MD, Denver, Colo; Richard Heese, MD, Ochsner Clinic, New Orleans, La; Barry Leader, MD, New Orleans; Robert Lehmann, MD, Lehmann Eye Center, Nacogdoches, Tex; Wayne March, MD, McGee Eye Institute, Oklahoma City, Okla; James McCulley, MD, Southwest Medical Center, Dallas, Tex; Robert Ritch, MD, New York (NY) Eye and Ear Infirmary; Doug Shin, MD, Kresge Eye Institute, Detroit, Mich; C. Eric Shrader, MD, Eye Clinic of Wichita (Kan); Richard Simmons, MD, Boston, Mass; Robert Stewart, MD, Houston (Tex)
Incorrect List of Investigators Published. Arch Ophthalmol. 1995;113(9):1112. doi:10.1001/archopht.1995.01100090034019
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.